Dihydropyrimido fused ring derivative as HBV inhibitor
First Claim
Patent Images
1. A compound represented by formula (I) or a pharmaceutically acceptable salt thereof,
2 Assignments
0 Petitions
Accused Products
Abstract
Disclosed is a dihydropyrimido fused ring derivative as a HBV inhibitor, and in particular relates to a compound shown as formula (I) or a pharmaceutically acceptable salt thereof.
28 Citations
18 Claims
- 1. A compound represented by formula (I) or a pharmaceutically acceptable salt thereof,
- 2. A compound or pharmaceutically acceptable salt thereof, having a structure shown as formula (II):
-
14. A compound or pharmaceutically acceptable salt thereof, selected from the following compounds:
Specification